JP2023103205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023103205A5 JP2023103205A5 JP2023060583A JP2023060583A JP2023103205A5 JP 2023103205 A5 JP2023103205 A5 JP 2023103205A5 JP 2023060583 A JP2023060583 A JP 2023060583A JP 2023060583 A JP2023060583 A JP 2023060583A JP 2023103205 A5 JP2023103205 A5 JP 2023103205A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- independently
- compound according
- butyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025116381A JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662353735P | 2016-06-23 | 2016-06-23 | |
| US62/353,735 | 2016-06-23 | ||
| JP2018567684A JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Division JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116381A Division JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023103205A JP2023103205A (ja) | 2023-07-26 |
| JP2023103205A5 true JP2023103205A5 (https=) | 2023-10-18 |
Family
ID=60675799
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Active JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
| JP2023060583A Pending JP2023103205A (ja) | 2016-06-23 | 2023-04-04 | 腫瘍死滅に影響する二重標的構築物 |
| JP2025116381A Pending JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Active JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116381A Pending JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10179117B2 (https=) |
| EP (2) | EP4520745A3 (https=) |
| JP (3) | JP7317505B2 (https=) |
| KR (2) | KR102513698B1 (https=) |
| CN (2) | CN109843339B (https=) |
| AU (2) | AU2017281364B2 (https=) |
| CA (1) | CA3028978A1 (https=) |
| IL (1) | IL263863B (https=) |
| SG (1) | SG11201811482YA (https=) |
| WO (1) | WO2017223357A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| BR112019002560B1 (pt) | 2016-08-10 | 2022-08-16 | Cancer Targeted Technology Llc | Composto, composição farmacêutica, seus usos e método de preparação do mesmo |
| EP3544960A1 (en) * | 2016-11-23 | 2019-10-02 | Cancer Targeted Technology LLC | Albumin-binding psma inhibitors |
| WO2018204477A1 (en) | 2017-05-02 | 2018-11-08 | Cornell University | Methods and reagents for tumor targeting with greater efficacy and less toxicity |
| KR102403970B1 (ko) * | 2018-12-27 | 2022-05-31 | (주)퓨쳐켐 | 카르복시산이 도입된 psma-표적 화합물 및 그의 용도 |
| MX2023006237A (es) * | 2020-11-30 | 2023-08-08 | Univ Cornell | Inmunoterapias para el cancer para promover el rechazo hiperagudo. |
| CN114685599A (zh) * | 2020-12-30 | 2022-07-01 | 南京江原安迪科正电子研究发展有限公司 | 一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途 |
| JP2024515104A (ja) | 2021-04-20 | 2024-04-04 | テラパワー， エルエルシー | Ａｃ－２２５生成のためのチタニアに基づくジェネレータ |
| CN115448856B (zh) * | 2022-09-30 | 2023-09-22 | 北京师范大学 | 一种用于靶向PSMA的EuK二聚体化合物、衍生物及其应用 |
| WO2025213026A1 (en) * | 2024-04-04 | 2025-10-09 | Lantheus Medical Imaging, Inc. | Astatine-211-labelled psma-binding compounds |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| EA012622B1 (ru) | 2004-06-01 | 2009-10-30 | Домэнтис Лимитед | Биспецифичные гибридные антитела с увеличенным периодом полувыведения из сыворотки |
| US20060252107A1 (en) | 2005-02-22 | 2006-11-09 | Acucela, Inc. | Compositions and methods for diagnosing and treating retinal diseases |
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| ES2847275T3 (es) * | 2006-11-08 | 2021-08-02 | Molecular Insight Pharm Inc | Heterodímeros de ácido glutámico |
| RU2494096C2 (ru) | 2008-08-01 | 2013-09-27 | Дзе Джонс Хопкинс Юниверсити | Агенты, связывающиеся с psma, и их применение |
| WO2010032248A2 (en) | 2008-09-17 | 2010-03-25 | Yeda Research And Development Co. Ltd. | Multifunctional albumin conjugates |
| TW201034691A (en) | 2008-12-05 | 2010-10-01 | Molecular Insight Pharm Inc | Technetium-and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| WO2010065899A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof |
| WO2013022797A1 (en) | 2011-08-05 | 2013-02-14 | Molecular Insight Pharmaceuticals | Radiolabeled prostate specific membrane antigen inhibitors |
| AU2012296937B2 (en) | 2011-08-17 | 2017-10-12 | Merck & Cie | Folate conjugates of albumin-binding entities |
| US20140079636A1 (en) | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| LT4095130T (lt) | 2013-10-18 | 2024-04-25 | Novartis Ag | Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti |
| US10140408B2 (en) | 2015-09-04 | 2018-11-27 | Qualcomm Incorporated | Selectively encrypting content for distribution from a receiver device to a companion device |
| WO2017070482A2 (en) | 2015-10-22 | 2017-04-27 | The Johns Hopkins University | Psma targeted radiohalogenated ureas for cancer radiotherapy |
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| IL315062A (en) | 2017-04-05 | 2024-10-01 | Univ Cornell | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| US11400165B2 (en) | 2017-11-04 | 2022-08-02 | Advanced Proteome Therapeutics Inc. | Composition and method for modifying polypeptides |
| EP3946320A4 (en) | 2019-04-03 | 2022-12-28 | Tva (Abc), Llc | CONJUGATES RELATED TO HSP90 AND FORMULATIONS THEREOF |
| CR20210556A (es) | 2019-05-10 | 2021-12-17 | Janssen Biotech Inc | Quelantes macrocíclicos y métodos de uso de estos |
| CA3070610A1 (en) | 2020-01-31 | 2021-07-31 | Humphrey FONGE | Methods and compositions for targeting disease related cell surface receptors using radiolabeled and/or cytotoxin labelled antibodies |
| US12151004B2 (en) | 2020-01-31 | 2024-11-26 | University Of Saskatchewan | Methods and compositions for targeting disease related cell surface receptors using radiolabeled and/or cytotoxin labelled antibodies |
| US20220143228A1 (en) | 2020-10-22 | 2022-05-12 | Actinium Pharmaceuticals, Inc. | Her3 radioimmunotherapy for the treatment of solid cancers |
| IL302759A (en) | 2020-11-10 | 2023-07-01 | Janssen Biotech Inc | Macrocyclic compounds and methods of use thereof |
| CA3205707A1 (en) | 2021-01-27 | 2022-08-04 | Fei Shen | Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their uses |
| GEAP202316335A (en) | 2021-02-01 | 2023-10-10 | Bayer Ag | Multimeric chelator compounds for use in targeted radiotherapy |
| WO2022249089A1 (en) | 2021-05-27 | 2022-12-01 | Janssen Biotech, Inc. | Compositions and methods for the treatment of prostate cancer |
| EP4392081A4 (en) | 2021-08-27 | 2025-11-19 | Janssen Biotech Inc | Anti-PSMA radioconjugates and their uses |
| MX2024002476A (es) | 2021-08-27 | 2024-05-20 | Janssen Biotech Inc | Anticuerpos anti-psma y usos de estos. |
| CN118317957A (zh) | 2021-09-29 | 2024-07-09 | 墨尔本大学 | 在靶向放射疗法应用中作为配体的含大环的化合物和其放射性标记的络合物 |
| WO2023084396A1 (en) | 2021-11-09 | 2023-05-19 | Janssen Biotech, Inc. | Macrocyclic compounds and methods of making the same |
| US20250145646A1 (en) | 2021-11-09 | 2025-05-08 | Janssen Biotech, Inc. | Macrocyclic compounds and diagnostic uses thereof |
-
2017
- 2017-06-22 CN CN201780046339.7A patent/CN109843339B/zh active Active
- 2017-06-22 JP JP2018567684A patent/JP7317505B2/ja active Active
- 2017-06-22 KR KR1020197001426A patent/KR102513698B1/ko active Active
- 2017-06-22 SG SG11201811482YA patent/SG11201811482YA/en unknown
- 2017-06-22 EP EP25153047.3A patent/EP4520745A3/en active Pending
- 2017-06-22 CA CA3028978A patent/CA3028978A1/en active Pending
- 2017-06-22 EP EP17816235.0A patent/EP3474903B1/en active Active
- 2017-06-22 KR KR1020237009535A patent/KR102864909B1/ko active Active
- 2017-06-22 WO PCT/US2017/038832 patent/WO2017223357A1/en not_active Ceased
- 2017-06-22 AU AU2017281364A patent/AU2017281364B2/en active Active
- 2017-06-22 US US15/630,808 patent/US10179117B2/en active Active
- 2017-06-22 CN CN202310698783.4A patent/CN117069621A/zh active Pending
-
2018
- 2018-12-20 IL IL263863A patent/IL263863B/en unknown
-
2019
- 2019-01-11 US US16/246,422 patent/US10716772B2/en active Active
-
2020
- 2020-06-19 US US16/906,956 patent/US12186288B2/en active Active
-
2023
- 2023-04-04 JP JP2023060583A patent/JP2023103205A/ja active Pending
- 2023-06-08 AU AU2023203581A patent/AU2023203581B2/en active Active
-
2025
- 2025-01-06 US US19/011,473 patent/US20260091008A1/en active Pending
- 2025-07-10 JP JP2025116381A patent/JP2025148450A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023103205A5 (https=) | ||
| JP2017095457A5 (https=) | ||
| JP2019535744A5 (https=) | ||
| JP2019535746A5 (https=) | ||
| JP2022071077A5 (https=) | ||
| JP2020517616A5 (https=) | ||
| IL266563B (en) | Heterocyclic compounds useful as pdk1 inhibitors | |
| CN115244058A (zh) | 嘧啶并二环类衍生物、其制备方法及其在医药上的应用 | |
| JP2020506951A5 (https=) | ||
| NZ758176A (en) | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | |
| JP2010501572A5 (https=) | ||
| CN115803325A (zh) | 一种egfr抑制剂及其制备方法和应用 | |
| JPWO2021055295A5 (https=) | ||
| JP2021534168A5 (https=) | ||
| JPWO2023099624A5 (https=) | ||
| JP2005500266A5 (https=) | ||
| JP2017509682A5 (https=) | ||
| RU2020113749A (ru) | Аналоги таиланстатина | |
| JP2021523169A5 (https=) | ||
| JP2020534300A5 (https=) | ||
| JP2009503110A5 (https=) | ||
| JP2017526662A5 (https=) | ||
| JP2020506884A5 (https=) | ||
| JP2021512046A5 (https=) | ||
| JP2002540152A5 (https=) |